strong start fy look forward robot
launch new product driver
result better expect driven top line opex
encourag beat driven out-performance across
divis cvg rtg mitg coupl ep guidanc rais look forward
see revenu guidanc achiev beat key pipelin
product track reiter buy rate share think today
result support thesi continu drive msd growth
near term potenti acceler given pipelin
contribut eas comp increas revenu ep forecast
factor slightli higher organ growth assumpt lower interest tax
think growth mitg rtg diabet help drive growth
see acceler next year increas pt base
ep estim still signific discount peer
fy revenu guidanc reiter ep rang rais
reiter guidanc organ growth fx neg impact
ep rang vs prior con
includ roughli neg impact fx unchang
number catalyst come next sever quarter could boost growth
multipl low risk tavr surgic robot new diabet sensor
pump micra av leadless pacemak
small beat across board divis
cvg sale con increas xfx guidanc msd
growth arrhythmia management includ growth leadless pacer good sign
upcom av launch mitg sale con increas xfx
guidanc growth surgic innov inn
respiratori gastro renal rtg sale con increas xfx
guidanc ldd growth brain therapi msd specialti lsd
growth spine off-set msd declin pain market continu weak
valuat still inexpens vs peer pathway higher growth
trade con ep april end compar peer like cy
fy
trade data key metric
compani account thomson reuter ub estim ub adjust ep state goodwill-rel charg adjust abnorm econom item analyst
judgement valuat base averag share price year base share price aug edt
report prepar ub secur llc analyst certif requir disclosur begin
page ub seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
valuat method risk statement
price target base ep risk price
target includ slowdown core cardio neuro spine surgic end market
increas competit establish larg cap compani competit
entrant differenti technolog delay key product approv
reject regulatori bodi inabl deliv top-lin growth meet
consensu expect top line miss guidanc consensu
bottom line delay robot launch timelin mitral project meet
expect chang regulatori environ lead longer lead
time higher bar approv
report prepar ub secur llc affili ub ag ub ag subsidiari branch affili
refer herein ub
inform way ub manag conflict maintain independ research product histor
perform inform certain addit disclosur concern ub research recommend pleas visit
www ub com/disclosur figur contain perform chart refer past past perform reliabl
indic futur result addit inform made avail upon request ub secur co limit licens
conduct secur invest consult busi china secur regulatori commiss ub act may act
princip debt secur relat deriv may subject report recommend
final august pm gmt ub design certain research depart member deriv
research analyst depart member publish research princip analysi price market
deriv provid inform reason suffici upon base decis enter deriv
transact deriv research analyst co-author research report equiti research analyst economist
deriv research analyst respons deriv invest view forecast and/or recommend
analyst certif research analyst primarili respons content research report whole part
certifi respect secur issuer analyst cover report view express
accur reflect person view secur issuer prepar independ manner
includ respect ub part compens directli indirectli relat
specif recommend view express research analyst research report
fsr mra
fsr mra
fsr mra
stock price expect rise within three month time
rate assign specif catalyst event
stock price expect fall within three month time
rate assign specif catalyst event
ub rate alloc june
compani coverag global within rate categori
compani within rate categori invest bank ib servic provid
within past month
compani coverag global within short-term rate categori
compani within short-term rate categori invest bank ib servic provid
within past month
definit forecast stock return fsr defin expect percentag price appreci plu gross dividend
yield next month case yield may base accru dividend market return assumpt
mra defin one-year local market interest rate plu proxi forecast equiti risk
premium review ur stock may flag ur analyst indic stock price target and/or
rate subject possibl chang near term usual respons event may affect invest case
valuat short-term rate reflect expect near-term three month perform stock
reflect chang fundament view invest case equiti price target invest horizon
except special case uk european invest fund rate definit buy posit
factor structur manag perform record discount neutral neutral factor structur
manag perform record discount sell neg factor structur manag perform record
discount band except cbe except standard band may grant invest
review committe irc factor consid irc includ stock volatil credit spread respect
compani debt result stock deem high low risk may subject higher lower band
relat rate except appli identifi compani disclosur tabl relev
research analyst contribut report employ non-u affili ub secur llc
registered/qualifi research analyst finra analyst may associ person ub secur llc
therefor subject finra restrict commun subject compani public appear
trade secur held research analyst account name affili analyst employ affili
contribut report follow
ub price local market close
rate tabl current publish rate prior report may recent stock
company/ent within past month client ub secur llc non-invest
bank securities-rel servic provid
company/ent within past month client ub secur llc non-secur
servic provid
within past month ub secur llc and/or affili receiv compens product
servic invest bank servic company/ent
ub ag affili subsidiari benefici own class compani common equiti
secur last month end prior month end report date less day
ub secur llc make market secur and/or adr compani
unless otherwis indic pleas refer valuat risk section within bodi report complet set
disclosur statement associ compani discuss report includ inform valuat risk
